Which RBE for iodine 125 in clinical applications?

This publication has 26 references indexed in Scilit:

• OER and RBE for 125I and 192Ir at low dose rateon mammalian cells
  Radiotherapy and Oncology, 1987
• Relative biological effectiveness of 125 sources in a murine brachytherapy model
  International Journal of Radiation Oncology*Biology*Physics, 1984
• The evaluation of an RBE for iodine 125 relative to iridium 192 from a human erythematous skin reaction using a new approach to skin scoring
  The British Journal of Radiology, 1983
• Some theoretical derivations relating to the tissue dosimetry of brachytherapy nuclides, with particular reference to iodine-125
  Medical Physics, 1983
• Studies with encapsulated 125I sources. II. determination of the relative biological effectiveness using cultured mammalian cells
  International Journal of Radiation Oncology*Biology*Physics, 1982
• Permanent and removable implants for the brachytherapy of brain tumors
  International Journal of Radiation Oncology*Biology*Physics, 1981
• A comparison of the biological effect of¹²⁵I and¹⁹²Ir gamma rays on the roots ofVicia fabausing a specially designed applicator
  The British Journal of Radiology, 1980
• Interstitial brachytherapy in cancer of the lung: A 20 year experience
  International Journal of Radiation Oncology*Biology*Physics, 1979
• A comparison of the biological effect of iodine 125 and tantalum 182 gamma rays usingvicia fabaroots
  The British Journal of Radiology, 1978
• Low energy radionuclides for permanent interstitial implantation
  American Journal of Roentgenology, 1976